Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sébastien Miranda"'
Autor:
A. Bogaert, Y. Fares, Sébastien Miranda, Ygal Benhamou, M. Grall, Y.C. Sinzogan-Eyoum, J. Lammens, Paul Billoir, G. Armengol, Hervé Levesque, K. Alexandre
Publikováno v:
JMV-Journal de Médecine Vasculaire. 46:163-170
Summary Introduction The COVID-19 pandemic is associated with a high incidence of venous thromboembolism questioning the utility of a systematic screening for deep venous thrombosis (DVT) in hospitalised patients. Methods In this prospective bicentri
Patients with refractory catastrophic antiphospholipid syndrome respond inconsistently to eculizumab
Autor:
Arsène Mekinian, Véronique Le Guern, Cécile Yelnik, Eric Hachulla, Thomas Quemeneur, Marie Frimat, Sébastien Miranda, Estibaliz Lazaro, François Provôt, Nathalie Costedoat-Chalumeau, Sandrine Morell-Dubois, Marc Lambert
Publikováno v:
Blood. 136:2473-2477
Autor:
Sébastien Miranda, Ygal Benhamou, Jeremy Bellien, Hervé Levesque, Robinson Joannides, Paul Billoir, M. Le Besnerais, Vincent Richard, G. Armengol
Publikováno v:
Lupus. 29:157-164
Introduction Antiphospholipid syndrome (APS) is associated with greater atherothrombotic risk and endothelial dysfunction, suggesting that endothelial glycocalyx is impaired in this disease. Objectives The aim was to investigate the endothelial glyco
Autor:
Salma Adham, G. Armengol, Nicole Cailleux-Talbot, Hervé Levesque, Sébastien Miranda, Ygal Benhamou
Publikováno v:
Vascular medicine (London, England). 26(6)
Publikováno v:
Thrombosis Research. 180:105-109
Suspected recurrent venous thromboembolism (VTE) is a common and vexing clinical problem. Confounding the diagnosis of recurrent VTE is a high frequency of residual VTE from prior VTE. The diagnosis of recurrent VTE must be established by comparing c
Publikováno v:
Critical care clinics. 36(3)
Given the broad treatment options, risk stratification of pulmonary embolism is a highly desirable component of management. The ideal tool identifies patients at risk of death from the original or recurrent pulmonary embolism. Using all-cause death i
Autor:
Shin Ahn, Philip S. Wells, Paul L. den Exter, Sébastien Miranda, Menno V. Huisman, Marc Carrier, Alok A. Khorana, Martha L Louzada, Aurélien Delluc, Adriano Alatri, Manuel Monreal
Publikováno v:
Haematologica
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Haematologica, vol. 105, no. 5, pp. 1436-1442
Haematologica, 105(5), 1436-1442. FERRATA STORTI FOUNDATION
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
Haematologica, vol. 105, no. 5, pp. 1436-1442
Haematologica, 105(5), 1436-1442. FERRATA STORTI FOUNDATION
In patients with cancer-associated venous thromboembolism, knowledge of the estimated rate of recurrent events is important for clinical decision-making regarding anticoagulant therapy. The Ottawa score is a clinical prediction rule designed for this
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e09dda0290262ea542c2e5c47b3e38c2
https://hdl.handle.net/1887/3184868
https://hdl.handle.net/1887/3184868
Autor:
Sébastien, Miranda, Hervé, Levesque
Publikováno v:
La Revue de medecine interne. 41(9)
Publikováno v:
Thrombosis and haemostasis. 119(11)
Autor:
Grégoire Le Gal, Siavash Piran, Aurélien Delluc, Junghyun Park, Sébastien Miranda, Shemina Kherani, Marc A. Rodger
Publikováno v:
Journal of thrombosis and haemostasis : JTHREFERENCES. 18(4)
BACKGROUND Antiphospholipid syndrome (APS) is an acquired thrombophilia disorder with prevalence not completely known in patients with first unprovoked venous thromboembolic events (VTE). Recent data suggest that the management of some APS patients s